Company Description
Albireo Pharma (NASDAQ: ALBO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
ALBO stock has gained 64.6% over the past year.
This page provides a comprehensive overview of ALBO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Albireo Pharma (ALBO) stock. Over the past 12 months, the stock has gained 64.6%.
Latest News
Albireo Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include fda approval, acquisition, management, conferences, earnings. View all ALBO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ALBO Company Profile & Sector Positioning
Albireo Pharma (ALBO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.